MENU
XLO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Xilio Therapeutics (XLO) Ownership - Who owns Xilio Therapeutics?
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments... Show more
Profile
Industry
N/A
Address
828 Winter Street
Phone
+1 857 524-2466
Employees
73
Web
https://www.xiliotx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
35M
P/E Ratio
N/A
Total Cash
55.29M
Projected Growth
N/A
Total Debt
8.14M
Revenue
6.34M
Risk (Beta)
-0.90
Dividend Yield
N/A
Total Cash/Share
1.07
Total Debt/Equity
N/A
Revenue/Share
0.14 USD as % of share price
Fundamentals
XLO
Capitalization
35M
P/E Ratio
N/A
Risk (Beta)
-0.90
Dividend Yield
N/A
Total Cash
55.3M
Total Cash/Share
1.07
Total Debt
8.14M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.14%
Revenue
6.34M
ROE
N/A
Book Value
17.6M
P/B Ratio
3.27
Cash Flow
N/A
Earnings
-1.09
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
2.21
Current Revenue Per Employee
23616.44
Dividends Per Share - Security
N/A
EBITDA
-58M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-88.24
Shares Held By Institutions
16.9M
Shares Outstanding - Current
51.8M
Total Liabilities
53.5M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-29.225
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
828 Winter Street
Phone
+1 857 524-2466
Employees
73
Web
https://www.xiliotx.com